Description:
Home Page: www.takeda.com
1-1, Nihonbashi-Honcho 2-chome
Tokyo,
103-8668
Japan
Phone:
81 3 3278 2111
Officers
| Name | Title |
|---|---|
| Mr. Christophe Weber | Pres, CEO & Representative Director |
| Mr. Constantine Saroukos | CFO & Representative Director |
| Dr. Andrew S. Plump | Pres of R&D and Representative Director |
| Dr. Seigo Izumo | Chair of Management Board |
| Mr. Haruhiko Hirate | Member of Management Board |
| Salvatore Alesci | Member of Management Board and Head of R&D Global Science & Biomedical Policy |
| Norimasa Takeda | Chief Accounting Officer & Corp. Controller |
| Mr. Iwaaki Taniguchi | Sr. VP of Corp. Fin. & Controlling Department |
| Mr. Gabriele Ricci | Chief Data & Technology Officer |
| Mr. Christopher David O'Reilly | Global Head of Investor Relations & Global Fin. |
Exchange: SA
Country: BR
Currency: Brazilian real (R$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 6.3694 |
|---|---|
| Trailing PE: | 17.9044 |
| Price-to-Book MRQ: | 0.4827 |
| Price-to-Sales TTM: | 0.0549 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 49095 |